To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/fda-approves-the-first-3d-printed-drug-product-300122483.html
SOURCE Aprecia Pharmaceuticals Company
| Contact: |
| Aprecia Pharmaceuticals Company
U.S. Food and Drug Administration (FDA) Email Contact 513.864.4114 Web: http://www.aprecia.com |
« Previous Page 1 | 2
